Patient outcomes

RLD-patient-outcomes-resmed

NIV has been shown to improve daytime arterial blood gases and the symptoms associated with respiratory failure in patients with a chest wall disorder.¹

Improved gas exchange with increased PO₂ and decreased PCO₂
Improved hemodynamics with decreased pulmonary artery pressure and increased right ventricular function
Reduced work of breathing
Normalised sleep patterns with fewer apneic episodes.
Fewer hospital admissions
Improved quality of life
Relief from dyspnoea

Reference

Nickol AH, Hart N, Hopkinson NS, Moxham J, Simonds A, Polkey MI. (2005) Mechanisms of improvement of respiratory failure in patients with restrictive thoracic disease treated with non-invasive ventilation. Thorax Sep; 60(9):754-60

More RLD

What is restrictive lung disease?

Restrictive lung disease refers to conditions in which breathing is restricted, and can lead to long-term respiratory failure.

Why is it important to treat restrictive lung disease?

Treating the breathing and sleeping issues caused by restrictive lung disease disorders can make a huge difference in your quality of life.

Treatment options for restrictive lung disease (RLD)

ResMed has developed therapy devices and ventilators that can help you feel better during the day and sleep better at night, so you can get the most out of life.

Manage your preferences regarding cookies

A cookie is a small piece of data that a website asks your browser to store on your computer or mobile device. Please choose whether our website may use statistic or / and marketing cookies, as explained below:

Required cookies

These cookies are essential to the functioning of the site.

Analytical cookies

These cookies allow ResMed to analyze the website usage to measure and improve performance.

Marketing cookies

These cookies are used to help better advertise depending on your interests.